TMCnet News
Valeant Pharmaceuticals To Present At 31st Annual J.P. Morgan Healthcare ConferenceMONTREAL, Jan. 2, 2013 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at 4:30 p.m. PT. The conference will be held at the Westin St. Francis in San Francisco, CA. A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com. (Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO) Contact Information:Laurie W. Little 949-461-6002 [email protected] SOURCE Valeant Pharmaceuticals International, Inc. |